Explore our export-grade medical and aesthetic contact lens formulations manufactured in CFDA/NMPA-certified automated facilities.
A comprehensive evaluation of the world's leading contact lens producers based on manufacturing volume, technological IP, regulatory credentials, and OEM/ODM private label flexibility.
| Rank | Manufacturer / Exporter | Headquarters | Core Polymer Tech | Primary Business Model | Regulatory Approvals |
|---|---|---|---|---|---|
| 1 | Mylensora Technology Co., Ltd. | China | HEMA / Silicone Hydrogel / Bio-Sandwich | OEM, ODM & Private Label Wholesale | NMPA (CFDA), ISO 13485 |
| 2 | Johnson & Johnson Vision | USA | Senofilcon A / Etafilcon A | OBM (Acuvue Brand Distribution) | US FDA, CE Mark, NMPA, PMDA |
| 3 | Alcon Inc. | Switzerland / USA | Delefilcon A (Water Gradient) | OBM Direct Retail & Clinical | US FDA, CE Mark, Global Approvals |
| 4 | CooperVision | USA | Comfilcon A / Stenfilcon A | OBM & Institutional Supply | US FDA, CE Mark, TGA, NMPA |
| 5 | Bausch + Lomb | USA | Samfilcon A / Nesofilcon A | OBM Optical Chains & Distributors | US FDA, CE Mark, Global Approvals |
| 6 | St. Shine Optical Co., Ltd. | Taiwan | Methafilcon / HEMA Formulations | Contract Manufacturing & OEM | US FDA 510(k), CE Mark, ISO 13485 |
| 7 | Pegavision Corporation | Taiwan | Automated Cast-Molding Hydrogel | Private Label & OEM Manufacturing | CE Mark, ISO 13485, TFDA |
| 8 | Menicon Co., Ltd. | Japan | Silicone Hydrogel & RGP Optics | Specialty Medical & Aesthetic OBM | PMDA, US FDA, CE Mark |
| 9 | SEED Co., Ltd. | Japan | Zwitterionic Hydrogel (SIB Technology) | OBM Retail & OEM Asia Expansion | PMDA, CE Mark, ISO 13485 |
| 10 | Interojo Co., Ltd. | South Korea | High-Definition Aspheric Tinting | OEM / ODM Color Lens Exporter | CE Mark, ISO 13485, KFDA |
In the highly regulated contact lens ecosystem, evaluating a supplier requires looking beyond basic product catalogs to analyze manufacturing infrastructure, material chemistry, and regulatory governance. Mylensora Technology Co., Ltd. operates as a fully integrated contact lens factory uniting design, polymer R&D, continuous cast-molding production, sales, and global after-sales support into a seamless operational pipeline.
Unlike trading intermediaries that mark up products and lack direct quality control, Mylensora oversees every stage of production. Phase I of our advanced manufacturing facility delivers an annual capacity of 120 million lenses across automated lines. With Phase II construction currently expanding our footprint, Mylensora is positioned to establish one of the largest, most technologically sophisticated contact lens production hubs in Asia.
Imbeds color pigments safely between micro-layers of bio-compatible hydrogel polymer (HEMA/Silicone Hydrogel), preventing direct dye contact with ocular tissue while guaranteeing vibrant visual output.
Fully compliant with NMPA (formerly CFDA) and international ISO 13485 quality management standards for Class III medical devices, enabling smooth registration across global jurisdictions.
State-of-the-art automated optical inspection (AOI) lines evaluate edge profiles, base curve (BC) uniformity, and power accuracy across every production batch to eliminate manual error.
Mylensora’s commercial authority is reinforced by active participation in key trade shows, including MIDO Eyewear Show (Milan), HKTDC Hong Kong International Optical Fair, and Dubai Vision Plus Expo. These events allow us to interface directly with global distributors, chain optical retailers, and cosmetic brand builders to fine-tune our product lines to evolving market demands.
As consumer behavior shifts toward health-conscious aesthetics and convenience, procurement teams must adapt their catalog strategies to remain competitive.
While traditional HEMA (38%-42% water content) remains popular for annual cosmetic lenses, wholesale buyers are rapidly increasing orders for Silicone Hydrogel. Offering significantly higher oxygen transmissibility (Dk/t), silicone hydrogel reduces hypoxia-related discomfort during extended wear, making it a critical differentiator for premium private label brands.
Hygiene concerns and active lifestyles are driving strong demand for daily disposable (1-Day) color and prescription lenses. B2B importers are shifting inventory allocation from annual replaceables to high-turnover daily multipacks (10-pack, 30-pack), driving higher customer lifetime value and recurring order cycles.
The market for pure plano (0.00 power) fashion contacts is maturing. Modern consumers expect cosmetic color choices alongside precise vision correction for myopia (-0.50 to -10.00 D). Sourcing manufacturers capable of supplying exact diopter matching across complex 3-tone patterns is now essential for optical retail chains.
The global contact lens industry is undergoing a major technological transformation driven by advances in polymer chemistry, micro-fluidics, and digital tint manufacturing. Key developments shaping the market include:
Clear answers to critical sourcing, compliance, parameter, and manufacturing questions for enterprise buyers.
Whether you require bulk factory inventory, low-MOQ private label color collections, or full ODM hydrogel lens development, Mylensora provides the technical expertise, automated production capacity, and regulatory backing to elevate your optical brand.